In vitro efficacy and fungicidal activity of voriconazole againstAspergillus andFusarium species
- 1 August 1998
- journal article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 17 (8) , 573-575
- https://doi.org/10.1007/bf01708622
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Do In Vitro Susceptibility Data Predict the Microbiologic Response to Amphotericin B? Results of a Prospective Study of Patients withCandidaFungemiaThe Journal of Infectious Diseases, 1998
- In vitro evaluation of voriconazole against some clinically important fungiAntimicrobial Agents and Chemotherapy, 1997
- Voriconazole (UK-109,496) inhibits the growth and alters the morphology of fluconazole-susceptible and -resistant Candida speciesAntimicrobial Agents and Chemotherapy, 1997
- Itraconazole resistance in Aspergillus fumigatusAntimicrobial Agents and Chemotherapy, 1997
- In vitro studies of activity of voriconazole (UK-109,496), a new triazole antifungal agent, against emerging and less-common mold pathogensAntimicrobial Agents and Chemotherapy, 1997
- In vitro Sensitivity of Medically Significant Fusarium Species to Various AntimycoticsChemotherapy, 1994
- Antifungal and Surgical Treatment of Invasive Aspergillosis: Review of 2,121 Published CasesClinical Infectious Diseases, 1990
- The Emerging Role of Fusarium Infections in Patients with CancerMedicine, 1988